Yuan Huiming, Fang Dalang, Wang Congjun, Zheng Kaitian, Oh Moon Young, Wang Ye, Chen Junqiang
Department of Gastrointestinal Gland Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, China.
Gland Surg. 2024 Nov 30;13(11):2163-2173. doi: 10.21037/gs-24-441. Epub 2024 Nov 26.
Observational studies have suggested an association between thyroid volume changes and thyroid disease, but the causal relationship and direction of these effects remain unclear. This study employs a two-sample Mendelian randomization (MR) approach to assess the effect of thyroid volume on clinically common benign and malignant thyroid diseases.
Summary data from genome-wide association studies (GWAS) were utilized for secondary data analysis to investigate the link between thyroid volume and disease. Gene loci strongly associated with thyroid volume were selected as the instrumental variables. Five complementary two-sample MR methods were used to evaluate the causal effect of thyroid volume on thyroid diseases and thyroid stimulating hormone (TSH).
Thyroid volume was found to be significantly associated with autoimmune thyroid disease [odds ratio (OR) =1.045; 95% confidence interval (CI): 1.022-1.069; P<0.001], Hashimoto's thyroiditis (OR =1.800; 95% CI: 1.167-2.778; P=0.008), Graves' disease (OR =0.136; 95% CI: 0.065-0.282; P<0.001), hyperthyroidism (OR =1.011; 95% CI: 1.008-1.014; P<0.001), multinodular goiters (OR =121.541; 95% CI: 23.323-633.378; P<0.001), non-toxic single thyroid nodules (OR =7.536; 95% CI: 2.280-24.911; P<0.001), benign thyroid neoplasms (OR =4.300; 95% CI: 1.170-15.802; P=0.03), and TSH levels (OR =0.401; 95% CI: 0.247-0.652; P<0.001). Thyroid volume was negatively associated with thyroid carcinomas (OR =0.401; 95% CI: 0.208-0.772; P=0.006; β =-0.915).
Our study found that there is a causal relationship between thyroid volume and some thyroid diseases, and that increased thyroid volume levels exert protective effects on thyroid carcinoma. Monitoring thyroid volume may be of value in the prevention of clinical thyroid diseases.
观察性研究表明甲状腺体积变化与甲状腺疾病之间存在关联,但这些影响的因果关系和方向仍不清楚。本研究采用两样本孟德尔随机化(MR)方法来评估甲状腺体积对临床常见的良性和恶性甲状腺疾病的影响。
利用全基因组关联研究(GWAS)的汇总数据进行二次数据分析,以研究甲状腺体积与疾病之间的联系。选择与甲状腺体积密切相关的基因位点作为工具变量。使用五种互补的两样本MR方法来评估甲状腺体积对甲状腺疾病和促甲状腺激素(TSH)的因果效应。
发现甲状腺体积与自身免疫性甲状腺疾病显著相关[比值比(OR)=1.045;95%置信区间(CI):1.022 - 1.069;P<0.001]、桥本甲状腺炎(OR =1.800;95%CI:1.167 - 2.778;P=0.008)、格雷夫斯病(OR =0.136;95%CI:0.065 - 0.282;P<0.001)、甲状腺功能亢进症(OR =1.011;95%CI:1.008 - 1.014;P<0.001)、多结节性甲状腺肿(OR =121.541;95%CI:23.323 - 633.378;P<0.001)、非毒性单个甲状腺结节(OR =7.536;95%CI:2.280 - 24.911;P<0.001)、良性甲状腺肿瘤(OR =4.300;95%CI:1.170 - 15.802;P=0.03)以及TSH水平(OR =0.401;95%CI:0.247 - 0.652;P<0.001)。甲状腺体积与甲状腺癌呈负相关(OR =0.401;95%CI:0.208 - 0.772;P=0.006;β = -0.915)。
我们的研究发现甲状腺体积与某些甲状腺疾病之间存在因果关系,且甲状腺体积增加对甲状腺癌具有保护作用。监测甲状腺体积可能对预防临床甲状腺疾病具有重要价值。